My comment at ForBetterScience.com👇
https://bit.ly/3RPS6wU
Venture capitalists funding rounds turn into main sources of funds for #BioTech startups
Some years ago, the US FDA adopted an "accelerated approval" pathway for therapies for serious diseases where approval depends on surrogate endpoints criteria, such as tumor shrinkage.
This is what we are seeing in the case of #Daraxonrasib and #Pancreatic #Cancer.
Durchbruch bei #Bauchspeicheldrüsenkrebs: Die experimentelle Pille namens #Daraxonrasib verdoppelt die Überlebenszeit. #Krebs www.fr.de/wissen/ueber...

Durchbruch bei Bauchspeicheldr...
Durchbruch bei Bauchspeicheldrüsenkrebs: Eine Pille verdoppelt die Überlebenszeit

Bauchspeicheldrüsenkrebs gilt als Todesurteil. Doch eine neue Pille ließ Patienten doppelt so lange leben. Dahinter steckt ein Trick aus der Natur.

“The company developing the drug, #RevolutionMedicines, presented results on May 31, 2026, from its Phase 3 clinical trial of 500 patients with metastatic #PancreaticCancer who had received prior treatment.
Compared to standard #chemotherapy, #daraxonrasib nearly doubled overall survival from 6.7 months to 13.2 months after diagnosis. Overall, daraxonrasib reduced the risk of death for metastatic pancreatic cancer patients by 60%.”

https://www.sciencealert.com/a-breakthrough-drug-just-achieved-the-impossible-for-pancreatic-cancer

A Breakthrough Drug Just Achieved The 'Impossible' For Pancreatic Cancer

For a long time, the likelihood of surviving pancreatic cancer has been extremely low.

ScienceAlert

Sobrevida de pacientes com câncer metastático dobra com nova pílula; risco de morte caiu em 60%

https://fed.brid.gy/r/https://iclnoticias.com.br/sobrevida-cancer-metastatico-dobra-pilula/

Pancreatic cancer pill that doubled survival may get Canada clinical trial
Medical oncologist Dr. Jennifer Knox independently reviewed a U.S.-led study of the experimental drug daraxonrasib and calls the results "amazing."
#Canada #Health #PancreaticCancer #PrincessMargaretCancerCentre
https://globalnews.ca/news/11888568/pancreatic-cancer-pill-that-doubled-survival-may-get-canadian-clinical-trial/
Pancreatic cancer pill that doubled survival may get Canada clinical trial
Medical oncologist Dr. Jennifer Knox independently reviewed a U.S.-led study of the experimental drug daraxonrasib and calls the results "amazing."
#Canada #Health #PancreaticCancer #PrincessMargaretCancerCentre
https://globalnews.ca/news/11888568/pancreatic-cancer-pill-that-doubled-survival-may-get-canadian-clinical-trial/
Pancreatic cancer pill that doubled survival may get Canada clinical trial
Medical oncologist Dr. Jennifer Knox independently reviewed a U.S.-led study of the experimental drug daraxonrasib and calls the results "amazing."
#Canada #Health #PancreaticCancer #PrincessMargaretCancerCentre
https://globalnews.ca/news/11888568/pancreatic-cancer-pill-that-doubled-survival-may-get-canadian-clinical-trial/
Pancreatic cancer pill that doubled survival may get Canada clinical trial
Medical oncologist Dr. Jennifer Knox independently reviewed a U.S.-led study of the experimental drug daraxonrasib and calls the results "amazing."
#Canada #Health #PancreaticCancer #PrincessMargaretCancerCentre
https://globalnews.ca/news/11888568/pancreatic-cancer-pill-that-doubled-survival-may-get-canadian-clinical-trial/
A drug just doubled survival time for pancreatic cancer. 40 years of federal research made it possible. Now that system is being dismantled. What cures will we never see? https://comuniq.xyz/post?t=1191 #CancerResearch #Daraxonrasib #ScienceFunding #PancreaticCancer
How to Know You're in the Wrong Career | Comuniq

Discover, vote and discuss the best content on the web. Comuniq is an open source community-driven news aggregator where real people — not algorithms — curate and share what matters most.